Sutro Biopharma, Inc.
NASDAQ:STRO
1.72 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8.52 | 25.706 | 13.008 | 113.721 | 16.924 | 10.412 | 12.674 | 8.632 | 25.147 | 28.096 | 5.897 | 10.654 | 8.517 | 28.049 | 14.66 | 8.278 | 17.823 | 9.469 | 7.152 | 11.305 | 12.277 | 10.525 | 8.629 | 19.086 | 7.836 | 5.704 | 5.793 | 4.04 | 17.499 | 15.101 | 15.101 |
| Cost of Revenue
| 0 | 62.02 | 1.761 | 1.731 | 1.739 | 2.395 | 2.256 | 2.158 | 2.081 | 2.053 | 29.99 | 2.403 | 26.602 | 25.309 | 22.562 | 22.738 | 19.361 | 17.243 | 17.619 | 17.392 | 16.897 | 16.143 | 15.18 | 14.787 | 12.642 | 13.751 | 13.082 | 12.398 | 13.669 | 12.915 | 12.915 |
| Gross Profit
| 8.52 | -36.314 | 11.247 | 111.99 | 15.185 | 8.017 | 10.418 | 6.474 | 23.066 | 26.043 | -24.093 | 8.251 | -18.085 | 2.74 | -7.902 | -14.46 | -1.538 | -7.774 | -10.467 | -6.087 | -4.62 | -5.618 | -6.551 | 4.299 | -4.806 | -8.047 | -7.289 | -8.358 | 3.83 | 2.186 | 2.186 |
| Gross Profit Ratio
| 1 | -1.413 | 0.865 | 0.985 | 0.897 | 0.77 | 0.822 | 0.75 | 0.917 | 0.927 | -4.086 | 0.774 | -2.123 | 0.098 | -0.539 | -1.747 | -0.086 | -0.821 | -1.464 | -0.538 | -0.376 | -0.534 | -0.759 | 0.225 | -0.613 | -1.411 | -1.258 | -2.069 | 0.219 | 0.145 | 0.145 |
| Reseach & Development Expenses
| 62.108 | 62.02 | 56.878 | 53.765 | 45.669 | 41.592 | 39.399 | 43.135 | 31.714 | 32.332 | 29.99 | 29.927 | 26.602 | 25.309 | 22.562 | 22.738 | 19.361 | 17.243 | 17.619 | 17.392 | 16.897 | 16.143 | 15.18 | 14.787 | 12.642 | 13.751 | 13.082 | 15.14 | 13.669 | 12.915 | 12.915 |
| General & Administrative Expenses
| 14.331 | 12.371 | 12.721 | 16.804 | 15.269 | 14.999 | 15.512 | 14.719 | 14.643 | 15.143 | 15.039 | 15.763 | 16.589 | 12.545 | 11.107 | 10.383 | 9.079 | 8.643 | 8.713 | 8.695 | 8.115 | 8.067 | 7.715 | 7.574 | 5.351 | 4.041 | 4.414 | 4.068 | 4.895 | 3.706 | 3.706 |
| Selling & Marketing Expenses
| 0 | 0 | -1.761 | -1.731 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.331 | 12.371 | 10.96 | 15.073 | 15.269 | 14.999 | 15.512 | 14.719 | 14.643 | 15.143 | 15.039 | 15.763 | 16.589 | 12.545 | 11.107 | 10.383 | 9.079 | 8.643 | 8.713 | 8.695 | 8.115 | 8.067 | 7.715 | 7.574 | 5.351 | 4.041 | 4.414 | 4.068 | 4.895 | 3.706 | 3.706 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.073 | -0.068 | 0 | 0 | 0.12 | -0.18 | 0 | 0 |
| Operating Expenses
| 76.439 | 74.391 | 67.838 | 68.838 | 60.938 | 56.591 | 54.911 | 57.854 | 46.357 | 47.475 | 45.029 | 45.69 | 43.191 | 37.854 | 33.669 | 33.121 | 28.44 | 25.886 | 26.332 | 26.087 | 25.012 | 24.21 | 22.895 | 22.361 | 17.993 | 17.792 | 17.496 | 19.208 | 18.564 | 3.714 | 3.714 |
| Operating Income
| -67.919 | -48.685 | -56.591 | 43.152 | -44.014 | -46.179 | -42.237 | -49.222 | -21.21 | -19.379 | -39.132 | -35.036 | -34.674 | -9.805 | -19.009 | -24.843 | -10.617 | -16.417 | -19.18 | -14.782 | -12.735 | -13.685 | -14.266 | -3.275 | -10.157 | -12.088 | -11.703 | -15.168 | -1.065 | -1.52 | -1.52 |
| Operating Income Ratio
| -7.972 | -1.894 | -4.35 | 0.379 | -2.601 | -4.435 | -3.333 | -5.702 | -0.843 | -0.69 | -6.636 | -3.289 | -4.071 | -0.35 | -1.297 | -3.001 | -0.596 | -1.734 | -2.682 | -1.308 | -1.037 | -1.3 | -1.653 | -0.172 | -1.296 | -2.119 | -2.02 | -3.754 | -0.061 | -0.101 | -0.101 |
| Total Other Income Expenses Net
| 19.132 | 0.675 | -1.622 | 3.72 | -3.431 | 7.806 | -7.418 | 14.628 | 1.722 | -4.133 | 0.022 | -3.089 | 3.772 | 3.653 | -11.35 | -34.701 | 27.756 | 46.289 | -0.415 | -0.007 | -0.177 | -0.108 | 0.016 | 1.782 | -0.08 | 0.547 | -0.343 | -0.176 | -0.353 | 0.057 | 0.057 |
| Income Before Tax
| -48.787 | -48.01 | -58.213 | 46.872 | -47.445 | -38.373 | -49.655 | -34.594 | -19.488 | -23.512 | -39.11 | -38.125 | -30.902 | -6.152 | -30.359 | -59.544 | 17.139 | 29.872 | -19.595 | -14.789 | -12.912 | -13.793 | -14.25 | -1.493 | -10.237 | -11.541 | -12.046 | -15.344 | -1.418 | -1.463 | -1.463 |
| Income Before Tax Ratio
| -5.726 | -1.868 | -4.475 | 0.412 | -2.803 | -3.685 | -3.918 | -4.008 | -0.775 | -0.837 | -6.632 | -3.578 | -3.628 | -0.219 | -2.071 | -7.193 | 0.962 | 3.155 | -2.74 | -1.308 | -1.052 | -1.31 | -1.651 | -0.078 | -1.306 | -2.023 | -2.079 | -3.798 | -0.081 | -0.097 | -0.097 |
| Income Tax Expense
| 0 | 0.008 | 1.718 | 15.807 | 1.839 | 0.151 | 0.395 | 2.5 | -1.722 | 2.5 | -0.022 | 0.612 | 0.82 | 0.847 | 0.858 | -2.251 | 2.317 | 2.955 | 0.641 | 0.81 | 0.964 | 1.124 | 1.176 | 1.497 | 0.347 | 0 | 0.04 | 0.497 | 0.055 | 0 | 0 |
| Net Income
| -48.787 | -48.018 | -58.213 | 31.065 | -49.284 | -38.524 | -50.05 | -37.094 | -17.766 | -26.012 | -39.088 | -38.125 | -30.902 | -6.152 | -30.359 | -59.544 | 17.139 | 29.872 | -19.595 | -14.789 | -12.912 | -13.793 | -14.25 | -1.493 | -10.237 | -11.541 | -12.046 | -15.344 | -1.418 | -1.463 | -1.463 |
| Net Income Ratio
| -5.726 | -1.868 | -4.475 | 0.273 | -2.912 | -3.7 | -3.949 | -4.297 | -0.706 | -0.926 | -6.628 | -3.578 | -3.628 | -0.219 | -2.071 | -7.193 | 0.962 | 3.155 | -2.74 | -1.308 | -1.052 | -1.31 | -1.651 | -0.078 | -1.306 | -2.023 | -2.079 | -3.798 | -0.081 | -0.097 | -0.097 |
| EPS
| -0.59 | -0.59 | -0.95 | 0.51 | -0.81 | -0.64 | -0.85 | -0.65 | -0.34 | -0.55 | -0.84 | -0.83 | -0.67 | -0.13 | -0.66 | -1.61 | 0.46 | 1 | -0.84 | -0.64 | -0.56 | -0.6 | -0.62 | -0.065 | -0.45 | -0.52 | -1.72 | -2.19 | -0.2 | -3.32 | -3.32 |
| EPS Diluted
| -0.59 | -0.59 | -0.95 | 0.51 | -0.81 | -0.64 | -0.85 | -0.65 | -0.34 | -0.55 | -0.84 | -0.83 | -0.67 | -0.13 | -0.66 | -1.61 | 0.45 | 0.94 | -0.84 | -0.64 | -0.56 | -0.6 | -0.62 | -0.065 | -0.45 | -0.52 | -1.72 | -2.19 | -0.2 | -3.32 | -3.32 |
| EBITDA
| -39.078 | -38.934 | -49.268 | 44.883 | -39.47 | -35.136 | -46.899 | -32.436 | -14.619 | -20.865 | -36.457 | -35.11 | -25.123 | -4.185 | -28.21 | -58.372 | -10.75 | -17.158 | -17.44 | -12.755 | -10.54 | -11.369 | -11.953 | 0.066 | -8.703 | -10.965 | -10.501 | -13.773 | 0.013 | -0.22 | -0.22 |
| EBITDA Ratio
| -4.587 | -1.515 | -4.215 | 0.395 | -2.601 | -3.996 | -3.131 | -5.279 | -0.746 | -0.633 | -6.391 | -3.156 | -3.927 | -0.303 | -1.195 | -2.837 | -0.525 | -1.581 | -2.438 | -1.128 | -0.859 | -1.08 | -1.385 | 0.003 | -1.111 | -1.922 | -1.813 | -3.409 | 0.001 | -0.015 | -0.015 |